-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
LUSTER-1 and -2: Two randomized controlled trials of the prostaglandin D2 receptor 2 antagonist, fevipiprant, in asthma
Barbara Knorr
Protocol: Clinical Investigation
-
LUSTER-1 and -2: Two randomized controlled trials of the prostaglandin D2 receptor 2 antagonist, fevipiprant, in asthma
Barbara Knorr
Protocol: Clinical Investigation
-
LUSTER-1 and -2: Two randomized controlled trials of the prostaglandin D2 receptor 2 antagonist, fevipiprant, in asthma
Barbara Knorr
Protocol: Clinical Investigation
-
LUSTER-1 and -2: Two randomized controlled trials of the prostaglandin D2 receptor 2 antagonist, fevipiprant, in asthma
Barbara Knorr
Protocol: Clinical Investigation
-
LUSTER-1 and -2: Two randomized controlled trials of the prostaglandin D2 receptor 2 antagonist, fevipiprant, in asthma
Barbara Knorr
Protocol: Clinical Investigation
-
LUSTER-1 and -2: Two randomized controlled trials of the prostaglandin D2 receptor 2 antagonist, fevipiprant, in asthma
Barbara Knorr
Protocol: Clinical Investigation
-
LUSTER-1 and -2: Two randomized controlled trials of the prostaglandin D2 receptor 2 antagonist, fevipiprant, in asthma
Barbara Knorr
Protocol: Clinical Investigation
-
LUSTER-1 and -2: Two randomized controlled trials of the prostaglandin D2 receptor 2 antagonist, fevipiprant, in asthma
Barbara Knorr
Protocol: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
Alzheimers disease clinical trials: past failures and future opportunities
Roy Yaari & Ann Hake
Clinical Trail Perspective: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Data Monitoring Committees in adaptive clinical trials
Min Lin, Shein-Chung Chow
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Lost in translation: will the personal become impersonal when conducting research in the age of technology?
Sue M Penckofer
Editorial: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Challenges and prospects for stem cell-based therapy in Type 1 diabetes
News and Views: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation